These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30046962)

  • 1. Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users.
    Grosgebauer K; Salinas J; Sharkey M; Roach M; Pallikkuth S; Dilworth SE; Pahwa S; Koru-Sengul T; Stevenson M; Carrico AW
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):16-22. PubMed ID: 30046962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection.
    Vidot DC; Manuzak JA; Klatt NR; Pallikkuth S; Roach M; Dilworth SE; Pahwa S; Carrico AW
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):361-364. PubMed ID: 30958388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    Carrico AW; Cherenack EM; Roach ME; Riley ED; Oni O; Dilworth SE; Shoptaw S; Hunt P; Roy S; Pallikkuth S; Pahwa S
    AIDS; 2018 Mar; 32(6):767-771. PubMed ID: 29369159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    Chahine A; Koru-Sengul T; Feaster DJ; Dilworth SE; Antoni MH; Klatt N; Roach ME; Pallikkuth S; Sharkey M; Salinas J; Stevenson M; Pahwa S; Fuchs D; Carrico AW
    J Acquir Immune Defic Syndr; 2021 Mar; 86(3):353-360. PubMed ID: 33165125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users.
    Carrico AW; Johnson MO; Colfax GN; Moskowitz JT
    AIDS Behav; 2010 Aug; 14(4):769-77. PubMed ID: 19125321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over the influence: The HIV care continuum among methamphetamine-using men who have sex with men.
    Jin H; Ogunbajo A; Mimiaga MJ; Duncan DT; Boyer E; Chai P; Dilworth SE; Carrico AW
    Drug Alcohol Depend; 2018 Nov; 192():125-128. PubMed ID: 30248558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.
    Parsons JT; Kowalczyk WJ; Botsko M; Tomassilli J; Golub SA
    AIDS Behav; 2013 May; 17(4):1478-87. PubMed ID: 23553345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
    Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.
    Starks TJ; Millar BM; Lassiter JM; Parsons JT
    AIDS Patient Care STDS; 2017 Feb; 31(2):78-86. PubMed ID: 28092450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explanations for methamphetamine use among gay and bisexual men in New York City.
    Halkitis PN; Fischgrund BN; Parsons JT
    Subst Use Misuse; 2005; 40(9-10):1331-45. PubMed ID: 16048820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the Function of TATA Box Binding Protein in Transcriptional Changes Induced by HIV-1 Tat in Innate Immune Cells and the Effect of Methamphetamine Exposure.
    Tjitro R; Campbell LA; Basova L; Johnson J; Najera JA; Lindsey A; Marcondes MCG
    Front Immunol; 2018; 9():3110. PubMed ID: 30778358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV.
    Brousseau NM; Kalichman SC; Watson RJ; Eaton LA
    AIDS Care; 2023 Oct; 35(10):1472-1479. PubMed ID: 37139536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
    D'Souza RR; Gopalan BP; Rajnala N; Phetsouphanh C; Shet A
    HIV Med; 2019 Sep; 20(8):513-522. PubMed ID: 31131542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Risk Behavior Among Methamphetamine Users Entering Substance Abuse Treatment in Cape Town, South Africa.
    Meade CS; Lion RR; Cordero DM; Watt MH; Joska JA; Gouse H; Burnhams W
    AIDS Behav; 2016 Oct; 20(10):2387-2397. PubMed ID: 26873492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine.
    Lee JY; Glynn TR; Moskowitz JT; Fuchs D; Neilands TB; Dilworth SE; Feaster DJ; Rodriguez A; Carrico AW
    J Neurovirol; 2021 Feb; 27(1):178-182. PubMed ID: 33460015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine and HIV.
    HRSA Careaction; 2009 Jun; ():1-8. PubMed ID: 19731419
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
    Carrico AW; Neilands TB; Dilworth SE; Evans JL; Gόmez W; Jain JP; Gandhi M; Shoptaw S; Horvath KJ; Coffin L; Discepola MV; Andrews R; Woods WJ; Feaster DJ; Moskowitz JT
    J Int AIDS Soc; 2019 Dec; 22(12):e25436. PubMed ID: 31860172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
    Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
    Front Immunol; 2021; 12():738743. PubMed ID: 34630420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis.
    Mahajan SD; Hu Z; Reynolds JL; Aalinkeel R; Schwartz SA; Nair MP
    Mol Diagn Ther; 2006; 10(4):257-69. PubMed ID: 16884330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.